Levels of plasmacytoid dendritic cells and type-2 myeloid dendritic cells are reduced in peripheral blood of patients with primary Sjögren's syndrome

Annals of the Rheumatic Diseases

Volumn 69, Issue 6, 2010, Pages 1235-1238

  Vogelsang, Petra ^a   Brun, Johan G ^a,b   Øijordsbakken, Gunnvor ^a   Skarstein, Kathrine ^a   Jonsson, Roland ^a,b   Appel, Silke ^a  

^a UNIVERSITY OF BERGEN   (Norway)

^b HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON; METHOTREXATE; STEROID;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BLOOD SAMPLING; CELL SUBPOPULATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; MYELOID DENDRITIC CELL; PLASMACYTOID DENDRITIC CELL; PRIORITY JOURNAL; SALIVARY GLAND; SEX RATIO; SJOEGREN SYNDROME;

ADOLESCENT; ADULT; AGED; AUTOANTIBODIES; CASE-CONTROL STUDIES; DENDRITIC CELLS; FEMALE; HUMANS; MALE; MIDDLE AGED; MYELOID CELLS; SALIVARY GLANDS, MINOR; SJOGREN'S SYNDROME; YOUNG ADULT;

EID: 77953710111     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/ard.2009.118158     Document Type: Article

References (19)

1. Jonsson R, Bolstad AI, Brokstad KA, et al. Sjögren's syndrome - a plethora of clinical and immunological phenotypes with a complex genetic background. Ann N Y Acad Sci 2007;1108:433-47.
2. Vitali C, Bombardieri S, Jonsson R, et al.; European Study Group on Classification Criteria for Sjögren's Syndrome. Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002;61:554-8.
3. Vogelsang P, Jonsson MV, Dalvin ST, et al. Role of dendritic cells in Sjögren's syndrome. Scand J Immunol 2006;64:219-26.
4. Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature 1998;392:245-52.
5. Fitzgerald-Bocarsly P, Dai J, Singh S. Plasmacytoid dendritic cells and type I IFN: 50 years of convergent history. Cytokine Growth Factor Rev 2008;19:3-19.
6. Steinman RM, Hawiger D, Nussenzweig MC. Tolerogenic dendritic cells. Annu Rev Immunol 2003;21:685-711.
7. Tarbell KV, Yamazaki S, Steinman RM. The interactions of dendritic cells with antigen-specific, regulatory T cells that suppress autoimmunity. Semin Immunol 2006;18:93-102.
8. Scheinecker C, Zwölfer B, Köller M, et al. Alterations of dendritic cells in systemic lupus erythematosus: phenotypic and functional deficiencies. Arthritis Rheum 2001;44:856-65.
9. Jongbloed SL, Lebre MC, Fraser AR, et al. Enumeration and phenotypical analysis of distinct dendritic cell subsets in psoriatic arthritis and rheumatoid arthritis. Arthritis Res Ther 2006;8:R15.
10. Chen X, Makala LH, Jin Y, et al. Type 1 diabetes patients have significantly lower frequency of plasmacytoid dendritic cells in the peripheral blood. Clin Immunol 2008;129:413-18.
11. Reksten TR, Jonsson MV, Szyszko EA, et al. Cytokine and autoantibody profiling related to histopathological features in primary Sjogren's syndrome. Rheumatology (Oxford) 2009;48:1102-6.
12. Salomonsson S, Jonsson MV, Skarstein K, et al. Cellular basis of ectopic germinal center formation and autoantibody production in the target organ of patients with Sjögren's syndrome. Arthritis Rheum 2003;48:3187-201.
13. Blanco P, Palucka AK, Gill M, et al. Induction of dendritic cell differentiation by IFN-alpha in systemic lupus erythematosus. Science 2001;294:1540-3.
14. Gill MA, Blanco P, Arce E, et al. Blood dendritic cells and DC-poietins in systemic lupus erythematosus. Hum Immunol 2002;63:1172-80.
15. Wildenberg ME, van Helden-Meeuwsen CG, van de Merwe JP, et al. Systemic increase in type I interferon activity in Sjögren's syndrome: a putative role for plasmacytoid dendritic cells. Eur J Immunol 2008;38:2024-33.
16. Båve U, Nordmark G, Lövgren T, et al. Activation of the type I interferon system in primary Sjögren's syndrome: a possible etiopathogenic mechanism. Arthritis Rheum 2005;52:1185-95.
17. Mavragani CP, Niewold TB, Moutsopoulos NM, et al. Augmented interferon-alpha pathway activation in patients with Sjogren's syndrome treated with etanercept. Arthritis Rheum 2007;56:3995-4004.
18. Niewold TB, Rivera TL, Buyon JP, et al. Serum type I interferon activity is dependent on maternal diagnosis in anti-SSA/Ro-positive mothers of children with neonatal lupus. Arthritis Rheum 2008;58:541-6.
19. Gottenberg JE, Cagnard N, Lucchesi C, et al. Activation of IFN pathways and plasmacytoid dendritic cell recruitment in target organs of primary Sjögren's syndrome. Proc Natl Acad Sci U S A 2006;103:2770-5.